Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • MAF translocation remains a st...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities

MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities

Bibliographic Details
Main Authors: Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Huishou Fan, Lingna Li, Jian Cui, Chenxing Du, Shuhui Deng, Weiwei Sui, Dehui Zou, Yan Xu, Lugui Qiu, Gang An
Format: Article
Language:English
Published: Ferrata Storti Foundation 2024-01-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11412
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/11412

Similar Items

  • Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma
    by: Jian Cui, et al.
    Published: (2023-08-01)
  • Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
    by: Wenqiang Yan, et al.
    Published: (2023-07-01)
  • P910: DOES MINIMAL RESIDUAL DISEASE OF STEM CELL COLLECTION HAVE PROGNOSTIC IMPACT ON PATIENTS WITH MULTIPLE MYELOMA?
    by: X. Jingyu, et al.
    Published: (2022-06-01)
  • The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma
    by: Huihsou Fan, et al.
    Published: (2023-12-01)
  • P935: EARLY RELAPSE WITHIN 18 MONTHS (ER18) IS A POWERFUL DYNAMIC PREDICTOR FOR PROGNOSIS AND COULD REVISE STATIC RISK DISTRIBUTION IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA
    by: Wenqiang Yan, et al.
    Published: (2023-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs